Delivery Order SPE2DB24D2010-SPE2DB25FABCU
- Not listed
- The Defense Logistics Agency awarded a $2,181.08 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 30 mg, a controlled pharmaceutical used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, which became effective on August 5, 2025 with an ultimate completion date of August 6, 2025, was awarded without a set-aside designation through open competition. The order will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $2,010.28 delivery order to AmerisourceBergen Drug Corp for 90 capsules of Lisdexamfetamine 60 mg, a controlled pharmaceutical product used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a $1,111.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count). This delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,137.22. This non-set-aside delivery order is scheduled for ultimate completion on August 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role...
- The Defense Logistics Agency awarded a $8,378.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-set-aside contract was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,968.50 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, with no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be performed and delivered from the...
- The Defense Logistics Agency awarded a $9,594.39 delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This is a $6,298.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug Lisdexamfetamine 40 mg capsules, a medication used to treat conditions such as attention deficit hyperactivity disorder (ADHD). The delivery order has an ultimate completion date of July 14, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,503.09 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count packaging). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified...
- The Defense Logistics Agency awarded a delivery order valued at $2,914.51 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 60 mg capsules (100 count) on August 19, 2025, with completion expected by August 20, 2025. This firm fixed price, competitively awarded delivery order represents a routine pharmaceutical procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, executed this...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABCUDelivery Order
The Defense Logistics Agency awarded a $2,949.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 40 mg, a controlled substance commonly prescribed for attention deficit hyperactivity disorder. This delivery order, issued on September 8, 2025, with completion targeted for September 9, 2025, represents a routine pharmaceutical procurement to support federal medical supply needs. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs and federal medical systems worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio of delivery orders with the DLA Medical Supply Chain, serving diverse healthcare requirements across the Department of Defense and supporting agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/8/25 |